Logo image of BACK

IMAC HOLDINGS INC (BACK) Stock Fundamental Analysis

NASDAQ:BACK - Nasdaq - US44967K3023 - Common Stock - Currency: USD

0.2  -0.22 (-52.65%)

After market: 0.1269 -0.07 (-36.55%)

Fundamental Rating

0

Taking everything into account, BACK scores 0 out of 10 in our fundamental rating. BACK was compared to 106 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BACK have multiple concerns. BACK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BACK has reported negative net income.
In the past year BACK has reported a negative cash flow from operations.
In the past 5 years BACK always reported negative net income.
In the past 5 years BACK always reported negative operating cash flow.
BACK Yearly Net Income VS EBIT VS OCF VS FCFBACK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -993.10%, BACK is not doing good in the industry: 97.27% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -993.1%
ROE N/A
ROIC N/A
ROA(3y)-342.4%
ROA(5y)-217.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BACK Yearly ROA, ROE, ROICBACK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

BACK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BACK Yearly Profit, Operating, Gross MarginsBACK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

More info and screens

0

2. Health

2.1 Basic Checks

BACK does not have a ROIC to compare to the WACC, probably because it is not profitable.
BACK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BACK has been increased compared to 5 years ago.
BACK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BACK Yearly Shares OutstandingBACK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
BACK Yearly Total Debt VS Total AssetsBACK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

BACK has an Altman-Z score of -76.94. This is a bad value and indicates that BACK is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BACK (-76.94) is worse than 93.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -76.94
ROIC/WACCN/A
WACC8.12%
BACK Yearly LT Debt VS Equity VS FCFBACK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M 15M

2.3 Liquidity

BACK has a Current Ratio of 0.08. This is a bad value and indicates that BACK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BACK (0.08) is worse than 92.73% of its industry peers.
A Quick Ratio of 0.08 indicates that BACK may have some problems paying its short term obligations.
BACK's Quick ratio of 0.08 is on the low side compared to the rest of the industry. BACK is outperformed by 92.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
BACK Yearly Current Assets VS Current LiabilitesBACK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

BACK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.07%, which is quite impressive.
The Revenue for BACK has decreased by -99.15% in the past year. This is quite bad
EPS 1Y (TTM)66.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.53%
Revenue 1Y (TTM)-99.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-96.42%

3.2 Future

BACK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.68% yearly.
The Revenue is expected to decrease by -41.42% on average over the next years. This is quite bad
EPS Next Y69.42%
EPS Next 2Y25.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BACK Yearly Revenue VS EstimatesBACK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
BACK Yearly EPS VS EstimatesBACK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BACK. In the last year negative earnings were reported.
Also next year BACK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BACK Price Earnings VS Forward Price EarningsBACK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BACK Per share dataBACK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

BACK's earnings are expected to grow with 25.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.68%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BACK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMAC HOLDINGS INC

NASDAQ:BACK (3/25/2025, 8:00:01 PM)

After market: 0.1269 -0.07 (-36.55%)

0.2

-0.22 (-52.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-17 2025-01-17/amc
Earnings (Next)04-14 2025-04-14
Inst Owners1.61%
Inst Owner Change0%
Ins Owners3.33%
Ins Owner Change9.41%
Market Cap674.00K
Analysts82.86
Price Target8.41 (4105%)
Short Float %4.17%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.38%
Min EPS beat(2)-283.24%
Max EPS beat(2)-55.51%
EPS beat(4)1
Avg EPS beat(4)-88.1%
Min EPS beat(4)-283.24%
Max EPS beat(4)62.29%
EPS beat(8)1
Avg EPS beat(8)-131.33%
EPS beat(12)2
Avg EPS beat(12)-105.9%
EPS beat(16)5
Avg EPS beat(16)-68.76%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.76
EYN/A
EPS(NY)-3.55
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0.02
BVpS-1.42
TBVpS-1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -993.1%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-342.4%
ROA(5y)-217.41%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -76.94
F-Score2
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.53%
EPS Next Y69.42%
EPS Next 2Y25.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-96.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.55%
OCF growth 3YN/A
OCF growth 5YN/A